Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
Parker
Christopher T
CT
Mewshaw
Elizabeth
E
Dennis
Gregory J
GJ
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D010865:Pilot Projects; D018570:Risk Assessment; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D008727:Methotrexate